key: cord-0711475-noujcwih
authors: Pati, Abhijit; Padhi, Sunali; Chaudhury, Sanskruti; Panda, Aditya K.
title: TLR3 (rs3775291) variant is not associated with SARS-CoV-2 infection and related mortality: a population-based correlation analysis
date: 2021-04-12
journal: Hum Cell
DOI: 10.1007/s13577-021-00530-2
sha: 9d687c2d88c4984492513394d16619b531085d50
doc_id: 711475
cord_uid: noujcwih

nan

To the Editor, With great interest, we read the recent article by Dhangadamajhi et al. [1] , which identified the possible association of TLR3 exonic variant (rs3775291) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and mortality rates in global populations. The authors included TLR3 rs3775291 polymorphism data of 48,835 healthy individuals from 40 countries and detected an important correlation between the rs3775291 minor allele and susceptibility to SARS-CoV-2 infection and mortality. An earlier study [2] used minor allele frequency data from 14 different countries to show a similar correlation between the rs3775291 variant and COVID-19 susceptibility and mortality. Although the data investigation and reporting were done elegantly and scholarly, we found a few minor issues that need to be discussed further.

1. To draw a firm conclusion in a population-scale analysis, all existing studies must be included. Genotype data from 48,835 healthy controls from 40 countries were used by the authors [1] . The minor allele frequency was obtained from 1000 genome projects and gnomAD, and other databases, such as PubMed and google scholar. After searching various databases (1000 genomes, gno-mAD, dbSNP, PubMed and google scholar) for minor allele frequency, we found more reports from various populations [Tunisia (n = 5), Brazil (n = 2), China (n = 13), South Korea (n = 4), Japan (n = 4), Scotland (n = 2), Spain (n = 3), Denmark (n = 3), Germany (n = 4), Poland (n = 2), Italy (n = 2), Finland (n = 3), and India (n = 5)]. When compared to the included reports of Dhangadamajhi et al. [1] , we were unable to trace allele frequency data from the Bulgarian population, and a smaller number of studies from the USA (n = 4) and Sweden cohorts (n = 2) were identified. 2. For population-scale correlation analysis, excluding reports that do not obey Hardy-Weinberg equilibrium (HWE) is critical. In line with this, Dhangadamajhi et al., proposed that such reports be removed from the correlation analysis. However, they erroneously included genotype data from Barbados (χ 2 = 4.536, p = 0.033) and Bangladesh (χ 2 = 3.775, p = 0.052) populations, which were deviated or very close to the HWE deviation score. 3. Despite the authors' claim that genotype data from 40 countries were used in the study, the number of countries considered for the population-scale analysis was actually 39. For the correlation study, the authors used minor allele frequency data from Finland twice. The minor allele data of Finland must be pooled before the correlation analysis. 4. The Pearson correlation test was used to assess the relationship between the prevalence of minor allele 'T' and the SARS-CoV-2 infection and mortality rate per million subjects in different populations. The Spearman rank correlation coefficient would be the most suitable [3] to test the relationship between TLR3 variant and COVID-19 since the two variables were on different scales and the analysis was not conducted in SARS-CoV-2 infected cases. Using data from Dhangadamajhi et al. [1] , a Spearman rank correlation study showed no significant association between SARS-CoV-2 and the TLR-3 rs3775291 polymorphism (infection: r = 0.244, p = 0.128; mortality: r = 0.247, p = 0.124). 5. For obtaining minor allele frequency in different populations, the authors used two different search strategies:

(1) genomic databases, such as 1000 Genomes Project and gnomAD, and (2) Table 1 . Reports with HWE deviated genotype distributions were omitted from the present analysis [Barbados (n = 1), Bangladesh (n = 1), China (n = 2), India (n = 1), Lithuania (n = 2), Nigeria (n = 1)] and a total of 47,136 healthy subjects from 35 different populations were taken into account. Using the modified minor allele frequency data, a reanalysis of the association between rs3775291 minor allele frequency and COVID-19 showed no significant correlation between rs3775291 minor allele 'T' and SARS-CoV-2 infection (Spearman r = 0.181, p = 0.295, n = 35) or mortality (Spearman r = 0.146, p = 0.402). Up-to-date data of SARS-CoV-2 infection and mortality rate per million were obtained from the Worldometer website (assessed on 1st April 2021). The spearman rank correlation study of rs3775291 minor allele frequency (T) with SARS-CoV-2 infection rate (Spearman r = 0.212, p = 0.221, n = 35) and mortality rate (Spearman r = 0.143, p = 0.412, n = 35) also failed to show a potential association of rs3775291 polymorphism with COVID-19, bolstering the absence of an association between rs3775291 and related mortality. However, case-control studies in different populations are needed to confirm our findings.

Association of TLR3 functional variant (rs3775291) with COVID-19 susceptibility and death: a population-scale study

Single-nucleotide polymorphisms in host pattern-recognition receptors show association with antiviral responses against SARS-CoV-2, in-silico trial

Demonstration of formulae for true measurement of correlation